Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2017

  • ID: 4410299
  • Report
  • 246 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Medical Optics Inc
  • Anew Optics, Inc.
  • Emmetrope Incorporated
  • LayerBio Inc
  • NuLens Ltd.
  • RxSight Inc
  • MORE
Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2017" provides an overview of Intraocular Lens (IOL) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Intraocular Lens (IOL) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Intraocular Lens (IOL) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Intraocular Lens (IOL) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Intraocular Lens (IOL) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Medical Optics Inc
  • Anew Optics, Inc.
  • Emmetrope Incorporated
  • LayerBio Inc
  • NuLens Ltd.
  • RxSight Inc
  • MORE
1 Table of Contents

2 Introduction
2.1 Intraocular Lens (IOL) Overview

3 Products under Development
3.1 Intraocular Lens (IOL) - Pipeline Products by Stage of Development
3.2 Intraocular Lens (IOL) - Pipeline Products by Segment
3.3 Intraocular Lens (IOL) - Pipeline Products by Territory
3.4 Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
3.5 Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
3.6 Intraocular Lens (IOL) - Ongoing Clinical Trials

4 Intraocular Lens (IOL) - Pipeline Products under Development by Companies
4.1 Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development
4.2 Intraocular Lens (IOL) - Pipeline Products by Stage of Development

5 Intraocular Lens (IOL) Companies and Product Overview
5.1 Abbott Medical Optics Inc Company Overview
5.1.1 Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adoptics AG (Inactive) Company Overview
5.2.1 Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.3 AkkoLens International BV Company Overview
5.3.1 AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview
5.4 Alcon Laboratories Inc Company Overview
5.4.1 Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Anew Optics, Inc. Company Overview
5.5.1 Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Bausch & Lomb Inc Company Overview
5.6.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Clarvista Medical, Inc. Company Overview
5.7.1 Clarvista Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Elenza, Inc. Company Overview
5.8.1 Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Emmetrope Incorporated Company Overview
5.9.1 Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview
5.10 Eye4Vision Ophthalmics International Company Overview
5.10.1 Eye4Vision Ophthalmics International Pipeline Products & Ongoing Clinical Trials Overview
5.11 EyeKon Medical Inc Company Overview
5.11.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Hoya Surgical Optics Inc Company Overview
5.12.1 Hoya Surgical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 IFS Construction Services Ltd Company Overview
5.13.1 IFS Construction Services Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 InfiniteVision Optics, SAS Company Overview
5.14.1 InfiniteVision Optics, SAS Pipeline Products & Ongoing Clinical Trials Overview
5.15 Innovia LLC Company Overview
5.15.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.16 LayerBio Inc Company Overview
5.16.1 LayerBio Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 LensGen, Inc. Company Overview
5.17.1 LensGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.18 London Eye Hospital Pharma Company Overview
5.18.1 London Eye Hospital Pharma Pipeline Products & Ongoing Clinical Trials Overview
5.19 Meir Medical Center Company Overview
5.19.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.20 Morcher Gmbh Company Overview
5.20.1 Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview
5.21 NuLens Ltd. (Inactive) Company Overview
5.21.1 NuLens Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.22 Ocumetics Technology Corp Company Overview
5.22.1 Ocumetics Technology Corp Pipeline Products & Ongoing Clinical Trials Overview
5.23 PowerVision, Inc. Company Overview
5.23.1 PowerVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.24 Presbeasy Company Overview
5.24.1 Presbeasy Pipeline Products & Ongoing Clinical Trials Overview
5.25 Rayner Intraocular Lenses Ltd Company Overview
5.25.1 Rayner Intraocular Lenses Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.26 RxSight Inc Company Overview
5.26.1 RxSight Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 Santen Pharmaceutical Co Ltd Company Overview
5.27.1 Santen Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.28 Sharklet Technologies, Inc. Company Overview
5.28.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.29 STAAR Surgical Company Overview
5.29.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview
5.30 Strathspey Crown LLC Company Overview
5.30.1 Strathspey Crown LLC Pipeline Products & Ongoing Clinical Trials Overview
5.31 University of Rochester Company Overview
5.31.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.32 University of Tampere Company Overview
5.32.1 University of Tampere Pipeline Products & Ongoing Clinical Trials Overview
5.33 Valeant Pharmaceuticals International Inc Company Overview
5.33.1 Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Visidome Ltd Company Overview
5.34.1 Visidome Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.35 Visioneering Technologies Inc Company Overview
5.35.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.36 Washington University in St Louis Company Overview
5.36.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
5.37 Xend Company Overview
5.37.1 Xend Pipeline Products & Ongoing Clinical Trials Overview
5.38 Z Lens LLC Company Overview
5.38.1 Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview

6 Intraocular Lens (IOL)- Recent Developments
6.1 Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With $1 Million to Help Families Affected by Hurricane Irma
6.2 Sep 15, 2017: Swiss Advanced Vision Announces Launch of New Intraocular Lens, LUCIDIS
6.3 Sep 15, 2017: Swiss Advanced Vision Announces Launch of New Intraocular Lens, EDEN
6.4 Sep 15, 2017: Valeant Commits $200,000 to Support Hurricane Relief Efforts
6.5 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index
6.6 Sep 07, 2017: Industry Leader Dr. Doug Benoit Joins VTI as Executive Director of Professional Affairs
6.7 Aug 15, 2017: World's fastest growing IOL Company - Opens Second Manufacturing Facility in Thailand
6.8 Aug 08, 2017: Valeant Announces Second-Quarter 2017 Results
6.9 Aug 02, 2017: STAAR Surgical Reports Second Quarter 2017 Results
6.10 Aug 01, 2017: Visioneering Technologies Announces Lynn Cali-Cianci As Executive Territory Manager, New York City/Long Island
6.11 Jul 27, 2017: Hoya Reports First Quarter Financial Results
6.12 Jul 25, 2017: Visioneering Technologies Appoints Lisa Humble as Senior Territory Manager For North and South Carolina
6.13 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results
6.14 Jul 20, 2017: Dr. Jim Raulino Joins the VTI Team as Executive Territory Manager for Sacramento and Reno
6.15 Jul 13, 2017: Visioneering Technologies Appoints Michelle Kirst as Territory Manager for New Jersey
6.16 Jul 11, 2017: Visioneering Technologies Appoints Ron Makelke as Territory Manager for San Francisco
6.17 Jul 06, 2017: Visioneering Technologies Appoints Carol Baez as Executive Territory Manager for Orange County/San Diego
6.18 Jun 27, 2017: Visioneering Technologies Names Mark Rapoport as New CFO
6.19 Jun 22, 2017: Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International
6.20 Jun 19, 2017: Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications
6.21 Jun 19, 2017: John Paulson Joins Valeant Board Of Directors
6.22 Jun 14, 2017: The Eye Institute of Utah Now Offering FDA-Approved Acrysof IQ ReSTOR +2.5 Multifocal Toric IOL with ACTIVEFOCUS for Cataract Surgery
6.23 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec
6.24 May 11, 2017: STAAR Surgical Announces CE Mark Approval for the EVO+ Visian ICL with Aspheric (EDOF) Optic
6.25 May 11, 2017: Hoya Reports Fourth Quarter and Full-Year Financial Results
6.26 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17
6.27 May 10, 2017: Santen Reports Fiscal 2016 Consolidated Performance
6.28 May 09, 2017: Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range
6.29 May 08, 2017: ZEISS Appoints New Fellow
6.30 May 08, 2017: Systemic therapy outperforms intraocular implant for treating uveitis
6.31 May 05, 2017: Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership
6.32 May 03, 2017: Las Vegas Cataract Surgeon Says the TECNIS Symfony Intraocular Lens Offers Patients an Excellent New Lifestyle Option
6.33 May 03, 2017: Alcon launches newly approved Multifocal Toric IOL with ACTIVEFOCUS optical design, highlights other surgical innovations at the American Society of Cataract and Refractive Surgery 2017 annual meeting
6.34 May 03, 2017: STAAR Surgical Reports First Quarter 2017 Results
6.35 Apr 25, 2017: ZEISS Opens New Microscopy Customer Center
6.36 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results
6.37 Apr 05, 2017: STAAR Surgical Names Deborah Andrews Interim CFO
6.38 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million
6.39 Mar 27, 2017: Carl Zeiss Meditec wins patent infringement action on trifocal intraocular lens against VSY Biotechnology and Fritz Ruck Ophthalmologische Systeme
6.40 Mar 23, 2017: Alcon Receives US FDA Approval For New AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL With ACTIVEFOCUS Design For Uncompromised Distance Vision And Presbyopia Correction
6.41 Mar 22, 2017: ClarVista Medical Completes Important Milestone to Advance Novel Modular Intraocular Lens for Cataract Lens Replacement
6.42 Mar 15, 2017: Santen Pharmaceutical: Notice of Corporate Officer Appointments
6.43 Mar 02, 2017: STAAR Surgical Reports Fourth Quarter 2016 Results
6.44 Feb 28, 2017: Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance
6.45 Feb 23, 2017: Calhoun Vision Becomes RxSight
6.46 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17
6.47 Feb 07, 2017: Santen Pharma Reports Revenue Of JPY150.7 Billion In Nine Months Ended December 31, 2016
6.48 Jan 31, 2017: Hoya Announces Third Quarter Financial Results
6.49 Jan 26, 2017: Alcon launches new trifocal toric intraocular lens for patients with astigmatism undergoing cataract surgery
6.50 Jan 17, 2017: Visioneering Technologies Announces Jeff Babbe as New Executive Territory Manager for Chicago, IL
6.51 Jan 04, 2017: Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors
6.52 Dec 23, 2016: Alcon receives US FDA approval for AcrySof IQ ReSTOR +3.0D Multifocal Toric intraocular lens for cataract patients
6.53 Dec 21, 2016: Visioneering Technologies Announces Brian Atkinson as Territory Manager for the Dallas/Ft. Worth Market
6.54 Dec 13, 2016: Visioneering Technologies Announces Ken Gold as New Executive Territory Manager for the Baltimore-Washington, DC Area
6.55 Dec 12, 2016: Valeant Appoints William D. Humphries As EVP, Dermatology
6.56 Dec 09, 2016: Carl Zeiss Meditec continues its growth trend
6.57 Dec 07, 2016: VTI names executive director of manufacturing and engineering
6.58 Dec 07, 2016: Visioneering Technologies Announces Ms. Rosa Lee as New Executive Director of Manufacturing & Engineering
6.59 Nov 17, 2016: Former Valeant Executive And Former Philidor Ceo Charged In Manhattan Federal Court For Illegal Fraud And Kickback Scheme
6.60 Nov 16, 2016: Center For Sight Offers Las Vegas Cataract Patients New Extended Depth of Focus Lens Implants for Reduced Dependence on Glasses
6.61 Nov 09, 2016: Redding Eye Surgeon Announces Arrival of FDA-Approved TECNIS Symfony Intraocular Lenses
6.62 Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results
6.63 Nov 03, 2016: STAAR Surgical Reports Third Quarter 2016 Results
6.64 Nov 02, 2016: Santen Consolidated Results for Q2 Fiscal 2016
6.65 Oct 28, 2016: Hoya Reports Second Quarter Results
6.66 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results
6.67 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer
6.68 Oct 12, 2016: Bausch + Lomb Booth to Feature Wet Lab During the Annual Meeting of the American Academy of Ophthalmology in Chicago
6.69 Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer
6.70 Oct 03, 2016: Santen: Personnel Changes of Corporate Officer

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Table 2: Intraocular Lens (IOL) - Pipeline Products by Segment
Table 3: Intraocular Lens (IOL) - Pipeline Products by Territory
Table 4: Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
Table 5: Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
Table 6: Intraocular Lens (IOL) - Ongoing Clinical Trials
Table 7: Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development
Table 8: Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Table 9: Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Intraocular Lens - Astigmatism - Product Status
Table 11: Intraocular Lens - Astigmatism - Product Description
Table 12: Intraocular Lens - Presbyopia - Product Status
Table 13: Intraocular Lens - Presbyopia - Product Description
Table 14: Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Shape-Changing Accommodating Intraocular Lens - Product Status
Table 16: Shape-Changing Accommodating Intraocular Lens - Product Description
Table 17: AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview
Table 18: AkkoLens AIOL - Product Status
Table 19: AkkoLens AIOL - Product Description
Table 20: Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Accommodative Intraocular Lens - Product Status
Table 22: Accommodative Intraocular Lens - Product Description
Table 23: AcrySof Cachet Angle-Supported Phakic Lens - Product Status
Table 24: AcrySof Cachet Angle-Supported Phakic Lens - Product Description
Table 25: AcrySof IQ PanOptix Toric IOL - Product Status
Table 26: AcrySof IQ PanOptix Toric IOL - Product Description
Table 27: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Status
Table 28: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Description
Table 29: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Status
Table 30: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Description
Table 31: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Status
Table 32: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Description
Table 33: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Status
Table 34: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Description
Table 35: AcrySof IQ Toric Diopter Range Expansion - Product Status
Table 36: AcrySof IQ Toric Diopter Range Expansion - Product Description
Table 37: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Status
Table 38: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Description
Table 39: Intrepid IOL - Product Status
Table 40: Intrepid IOL - Product Description
Table 41: Alcon Laboratories Inc - Ongoing Clinical Trials Overview
Table 42: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Patient-reported Satisfaction and Spectacle Independence with the ReSTOR 2.5 Combined with the ReSTOR 3.0 IOL in Cataract Surgery
Table 43: Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Zephyr Lens - Product Status
Table 45: Zephyr Lens - Product Description
Table 46: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Sarfarazi Elliptical Accommodating IOL - Product Status
Table 48: Sarfarazi Elliptical Accommodating IOL - Product Description
Table 49: Clarvista Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 50: HARMONI Modular IOL - Product Status
Table 51: HARMONI Modular IOL - Product Description
Table 52: Second Generation HARMONI System - Product Status
Table 53: Second Generation HARMONI System - Product Description
Table 54: Clarvista Medical, Inc. - Ongoing Clinical Trials Overview
Table 55: HARMONI Modular IOL - Feasibility of HARMONI Modular IOL in Restoration of Vision of Patients after Cataract Surgery
Table 56: Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Sapphire Autofocal IOL - Product Status
Table 58: Sapphire Autofocal IOL - Product Description
Table 59: Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview
Table 60: ActaLens - Product Status
Table 61: ActaLens - Product Description
Table 62: ActaLens-Duo - Product Status
Table 63: ActaLens-Duo - Product Description
Table 64: ActaLens-SC - Product Status
Table 65: ActaLens-SC - Product Description
Table 66: Eye4Vision Ophthalmics International Pipeline Products & Ongoing Clinical Trials Overview
Table 67: HYDROPHOBICx - Product Status
Table 68: HYDROPHOBICx - Product Description
Table 69: EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 70: ACUITY FA55A-4NY IOL - Product Status
Table 71: ACUITY FA55A-4NY IOL - Product Description
Table 72: Acuity FA55A-4UV IOL - Product Status
Table 73: Acuity FA55A-4UV IOL - Product Description
Table 74: Acuity FB25B - UV IOL - Product Status
Table 75: Acuity FB25B - UV IOL - Product Description
Table 76: Acuity FB25B-NY IOL - Product Status
Table 77: Acuity FB25B-NY IOL - Product Description
Table 78: Acuity FS25B-NY IOL - Product Status
Table 79: Acuity FS25B-NY IOL - Product Description
Table 80: Acuity FS25B-UV IOL - Product Status
Table 81: Acuity FS25B-UV IOL - Product Description
Table 82: Acuity FS60S - 4NY IOL - Product Status
Table 83: Acuity FS60S - 4NY IOL - Product Description
Table 84: Acuity FS60S - 4UV IOL - Product Status
Table 85: Acuity FS60S - 4UV IOL - Product Description
Table 86: Acuity TN60-2NY IOL - Product Status
Table 87: Acuity TN60-2NY IOL - Product Description
Table 88: Acuity TN60-OUV IOL - Product Status
Table 89: Acuity TN60-OUV IOL - Product Description
Table 90: Acurus AB60 - OUV IOL - Product Status
Table 91: Acurus AB60 - OUV IOL - Product Description
Table 92: Acurus AY60 - OUV IOL - Product Status
Table 93: Acurus AY60 - OUV IOL - Product Description
Table 94: AQ204 Natural Clear IOL - Product Status
Table 95: AQ204 Natural Clear IOL - Product Description
Table 96: Cirrus CB60-OUV IOL - Product Status
Table 97: Cirrus CB60-OUV IOL - Product Description
Table 98: Cirrus CN60-2NY IOL - Product Status
Table 99: Cirrus CN60-2NY IOL - Product Description
Table 100: Cirrus CN60-OUV IOL - Product Status
Table 101: Cirrus CN60-OUV IOL - Product Description
Table 102: Cirrus CS25B-1 IOL - Product Status
Table 103: Cirrus CS25B-1 IOL - Product Description
Table 104: Cirrus CS25B-NY IOL - Product Status
Table 105: Cirrus CS25B-NY IOL - Product Description
Table 106: Cirrus CS60S-4 IOL - Product Status
Table 107: Cirrus CS60S-4 IOL - Product Description
Table 108: Cirrus CS60S-4NY IOL - Product Status
Table 109: Cirrus CS60S-4NY IOL - Product Description
Table 110: Cirrus CY60-OUV IOL - Product Status
Table 111: Cirrus CY60-OUV IOL - Product Description
Table 112: DGR AS55A-4NY IOL - Product Status
Table 113: DGR AS55A-4NY IOL - Product Description
Table 114: DGR AS55A-4UV IOL - Product Status
Table 115: DGR AS55A-4UV IOL - Product Description
Table 116: DGR DB60B-OUV IOL - Product Status
Table 117: DGR DB60B-OUV IOL - Product Description
Table 118: DGR DN60B-2NY IOL - Product Status
Table 119: DGR DN60B-2NY IOL - Product Description
Table 120: DGR DN60B-OUV IOL - Product Status
Table 121: DGR DN60B-OUV IOL - Product Description
Table 122: DGR DY60B-OUV IOL - Product Status
Table 123: DGR DY60B-OUV IOL - Product Description
Table 124: DGR SB25B IOL - Product Status
Table 125: DGR SB25B IOL - Product Description
Table 126: DGR SB25B-NY IOL - Product Status
Table 127: DGR SB25B-NY IOL - Product Description
Table 128: DGR SC25B-ONY IOL - Product Status
Table 129: DGR SC25B-ONY IOL - Product Description
Table 130: DGR SC25B-OUV IOL - Product Status
Table 131: DGR SC25B-OUV IOL - Product Description
Table 132: DGR SP60S-4NY IOL - Product Status
Table 133: DGR SP60S-4NY IOL - Product Description
Table 134: DGR SP60S-4UV IOL - Product Status
Table 135: DGR SP60S-4UV IOL - Product Description
Table 136: DGR ZF25B-ONY IOL - Product Status
Table 137: DGR ZF25B-ONY IOL - Product Description
Table 138: DGR ZF25B-OUV IOL - Product Status
Table 139: DGR ZF25B-OUV IOL - Product Description
Table 140: Eyekon EA55A IOL - Product Status
Table 141: Eyekon EA55A IOL - Product Description
Table 142: EyeKon EA55A NY IOL - Product Status
Table 143: EyeKon EA55A NY IOL - Product Description
Table 144: Eyekon EQ624 IOL - Product Status
Table 145: Eyekon EQ624 IOL - Product Description
Table 146: Eyekon EQ624 NY IOL - Product Status
Table 147: Eyekon EQ624 NY IOL - Product Description
Table 148: Eyekon HB60-OUV IOL - Product Status
Table 149: Eyekon HB60-OUV IOL - Product Description
Table 150: EyeKon HB60BF - NY IOL - Product Status
Table 151: EyeKon HB60BF - NY IOL - Product Description
Table 152: EyeKon HB60BF Natural Clear IOL - Product Status
Table 153: EyeKon HB60BF Natural Clear IOL - Product Description
Table 154: EyeKon HY60 OUV IOL - Product Status
Table 155: EyeKon HY60 OUV IOL - Product Description
Table 156: Eyekon MC25B - OUV IOL - Product Status
Table 157: Eyekon MC25B - OUV IOL - Product Description
Table 158: Eyekon MC60S - 4NY IOL - Product Status
Table 159: Eyekon MC60S - 4NY IOL - Product Description
Table 160: Eyekon MC60S - 4UV IOL - Product Status
Table 161: Eyekon MC60S - 4UV IOL - Product Description
Table 162: Eyekon MN60-OUV IOL - Product Status
Table 163: Eyekon MN60-OUV IOL - Product Description
Table 164: EyeKon NY204 IOL - Product Status
Table 165: EyeKon NY204 IOL - Product Description
Table 166: Eyekon NY25-Fold IOL - Product Status

List of Figures
Figure 1: Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Figure 2: Intraocular Lens (IOL) - Pipeline Products by Segment
Figure 3: Intraocular Lens (IOL) - Pipeline Products by Territory
Figure 4: Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
Figure 5: Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
Figure 6: Intraocular Lens (IOL) - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Medical Optics Inc
  • Adoptics AG
  • AkkoLens International BV
  • Alcon Laboratories Inc
  • Anew Optics, Inc.
  • Bausch & Lomb Inc
  • Clarvista Medical, Inc.
  • Elenza, Inc.
  • Emmetrope Incorporated
  • Eye4Vision Ophthalmics International
  • EyeKon Medical Inc
  • Hoya Surgical Optics Inc
  • IFS Construction Services Ltd
  • InfiniteVision Optics, SAS
  • Innovia LLC
  • LayerBio Inc
  • LensGen, Inc.
  • London Eye Hospital Pharma
  • Meir Medical Center
  • Morcher Gmbh
  • NuLens Ltd.
  • Ocumetics Technology Corp
  • PowerVision, Inc.
  • Presbeasy
  • Rayner Intraocular Lenses Ltd
  • RxSight Inc
  • Santen Pharmaceutical Co Ltd
  • Sharklet Technologies, Inc.
  • STAAR Surgical Company
  • Strathspey Crown LLC
  • University of Rochester
  • University of Tampere
  • Valeant Pharmaceuticals International Inc
  • Visidome Ltd
  • Visioneering Technologies Inc
  • Washington University in St Louis
  • Xend
  • Z Lens LLC
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll